Estadístiques de Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
Visites totals
| views | |
|---|---|
| Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer | 64 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 1 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| adam-sca-targ.pdf(legacy) | 167 |
| adam-sca-targ.pdf | 29 |
Vistes principals per país
| views | |
|---|---|
| United States | 46 |
| Spain | 8 |
| India | 3 |
| Australia | 2 |
| Ireland | 2 |
| Bangladesh | 1 |
| France | 1 |
| Honduras | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Barcelona | 7 |
| Mountain View | 6 |
| San Ramon | 5 |
| Fairfield | 3 |
| Tustin | 3 |
| Boardman | 2 |
| Dublin | 2 |
| Jaipur | 2 |
| Menlo Park | 2 |
| Redmond | 2 |
| Andover | 1 |
| Ann Arbor | 1 |
| Bangalore | 1 |
| Cambridge | 1 |
| Dearborn | 1 |
| Maryborough | 1 |
| Moe | 1 |
| Paris | 1 |
| Pilas | 1 |
| Rochester | 1 |
| Sacramento | 1 |
| San Diego | 1 |